[HTML][HTML] Radiographic changes after lung stereotactic ablative radiotherapy (SABR)–can we distinguish recurrence from fibrosis? A systematic review of the literature
K Huang, M Dahele, S Senan, M Guckenberger… - Radiotherapy and …, 2012 - Elsevier
BACKGROUND: Changes in lung density on computed tomography (CT) are common after
stereotactic ablative radiotherapy (SABR) and can confound the early detection of …
stereotactic ablative radiotherapy (SABR) and can confound the early detection of …
Joint EANM/SNMMI/ESTRO practice recommendations for the use of 2-[18F]FDG PET/CT external beam radiation treatment planning in lung cancer V1.0
SC Vaz, JA Adam, RCD Bolton, P Vera… - European journal of …, 2022 - Springer
Abstract Purpose 2-[18 F] FDG PET/CT is of utmost importance for radiation treatment (RT)
planning and response monitoring in lung cancer patients, in both non-small and small cell …
planning and response monitoring in lung cancer patients, in both non-small and small cell …
Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients
M Taremi, A Hope, M Dahele, S Pearson… - International Journal of …, 2012 - Elsevier
PURPOSE: To present the results of stereotactic body radiotherapy (SBRT) for medically
inoperable patients with Stage I non–small-cell lung cancer (NSCLC) and contrast outcomes …
inoperable patients with Stage I non–small-cell lung cancer (NSCLC) and contrast outcomes …
Clinical outcome and predictors of survival and pneumonitis after stereotactic ablative radiotherapy for stage I non-small cell lung cancer
JY Chang, H Liu, P Balter, R Komaki, Z Liao, J Welsh… - Radiation …, 2012 - Springer
Background Stereotactic ablative radiotherapy (SABR) can achieve excellent local control
rates in early-stage non-small cell lung cancer (NSCLC) and has emerged as a standard …
rates in early-stage non-small cell lung cancer (NSCLC) and has emerged as a standard …
[HTML][HTML] Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients …
Background The aim of this study was to perform a survival comparison between stereotactic
body radiotherapy (SBRT) and sublobar resection (SLR) in patients with stage I non-small …
body radiotherapy (SBRT) and sublobar resection (SLR) in patients with stage I non-small …
Response assessment using 18F-FDG PET early in the course of radiotherapy correlates with survival in advanced-stage non–small cell lung cancer
W van Elmpt, M Öllers, AMC Dingemans… - Journal of Nuclear …, 2012 - Soc Nuclear Med
This study investigated the possibility of early response assessment based on 18F-FDG
uptake during radiotherapy with respect to overall survival in patients with non–small cell …
uptake during radiotherapy with respect to overall survival in patients with non–small cell …
Positron emission tomography for assessing local failure after stereotactic body radiotherapy for non-small-cell lung cancer
X Zhang, H Liu, P Balter, PK Allen, R Komaki… - International Journal of …, 2012 - Elsevier
PURPOSE: We analyzed whether positron emission tomography (PET)/computed
tomography standardized uptake values (SUVs) after stereotactic body radiotherapy (SBRT) …
tomography standardized uptake values (SUVs) after stereotactic body radiotherapy (SBRT) …
Stereotactic body radiotherapy (SBRT) for non-small cell lung cancer (NSCLC): is FDG-PET a predictor of outcome?
K Clarke, M Taremi, M Dahele, M Freeman… - Radiotherapy and …, 2012 - Elsevier
BACKGROUND AND PURPOSE: Distant metastases are the dominant mode of failure after
stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) …
stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer (NSCLC) …
Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer
A Takeda, E Kunieda, H Fujii, N Yokosuka, Y Aoki… - Lung cancer, 2013 - Elsevier
PURPOSE: Stereotactic body radiotherapy (SBRT) is the standard care for medically
inoperable early non-small-cell lung cancer (NSCLC). However, it can be difficult to …
inoperable early non-small-cell lung cancer (NSCLC). However, it can be difficult to …
[HTML][HTML] Follow-up of patients after stereotactic radiation for lung cancer: a primer for the nonradiation oncologist
K Huang, DA Palma… - Journal of Thoracic …, 2015 - Elsevier
Background The use of stereotactic ablative radiotherapy (SABR) as primary treatment for
early stage non–small-cell lung cancer, or for ablation of metastases, has increased rapidly …
early stage non–small-cell lung cancer, or for ablation of metastases, has increased rapidly …